21 completed, 2 terminated, 1 not yet recruiting, 1 withdrawn. 9 Phase 3, 7 Not applicable, 5 Phase 4, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 8, Terminated 1 |
| Not applicable | 7 | Completed 6, Not yet recruiting 1 |
| Phase 4 | 5 | Completed 4, Withdrawn 1 |
| Phase 2 | 4 | Completed 3, Terminated 1 |
Follow Chromogranins: new trials by email Literature Review of Chromogranins trials Research Report on Chromogranins
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Comparative Study of the Antibacterial Effects of Two Preoperative Hair Removal Methods in Male Patients With Urethral Stricture Wiping with wet wipes containing 2% chlorhexidine gluconate (CHG). - Urethral Stricture | Not applicable | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 40 | 2026-04-01 | 2026-04-02 |
| Effect of Bed Bathing Methods on VRE Colonization in ICU Patients Bed Bath, Disposable antibacterial bed bath wipes, Chlorhexidine gluconate 4% - Vancomycin-Resistant Enterococcus | Not applicable | Completed | Özkan Kasap | 210 | 2024-09-01 | 2026-05-07 |
| Chlorhexidine to Prevent Catheter-related Urinary Tract Infection Long Intervention, Mid-length Intervention, Short Intervention - Urinary Tract Infections | Not applicable | Completed | National Taiwan University Hospital | 30994 | 2023-03-01 | 2024-07-08 |
| Randomized Controlled Trial Comparing Irrisept Versus Normal Saline for Wound Irrigation After Posterior Spine Surgery saline 0.9%, (0.05% chlorhexidine gluconate (CHG) in sterile water) - Lumbar Spine Degeneration, Cervical Spine Degeneration | Phase 4 | Withdrawn | University of Missouri-Columbia | 2022-07-01 | 2022-12-27 | |
| Chlorhexidine Gluconate-gel Dressing for Exit Site Infection in Peritoneal Dialysis Chlorhexidine Gluconate-gel (CHG) Dressing - Peritoneal Dialysis Catheter Exit Site Infection, End Stage Renal Disease on Dialysis | Not applicable | Completed | National Healthcare Group, Singapore | 30 | 2019-09-27 | 2023-09-05 |
| Antimicrobial Dressing Versus Standard Dressing in Obese Women Undergoing Cesarean Delivery ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG), Standard Wound Care - Cesarean Section Complications, Wound Breakdown | Phase 4 | Completed | The University of Texas Medical Branch, Galveston | 154 | 2019-04-18 | 2021-10-05 |
| In-vivo Efficacy of Patient Preoperative Prep, ZuraPrep (ZP) ZuraPrep Clear Solution, ChloraPrep, ZuraPrep Vehicle - Surgical Skin Preparation | Phase 3 | Completed | Zurex Pharma, Inc. | 156 | 2019-01-25 | 2023-02-08 |
| Pre-operative Aqueous Antiseptic Skin Solutions in Open Fractures 10% povidone-iodine (1% free iodine) in purified water, 4% chlorhexidine gluconate (CHG) in purified water - Surgical Site Infection, Unplanned Fracture-Related Reoperation | Phase 4 | Completed | University of Maryland, Baltimore | 1638 | 2018-04-08 | 2023-03-31 |
| In Vivo Preoperative Skin Preparation Efficacy Study Within a Defined Product Coverage Area 3M CHG/IPA Prep - Surgical Skin Preparation, Surgical Procedure, Unspecified | Phase 2 | Completed | Solventum US LLC | 28 | 2017-06-06 | 2024-10-02 |
| Evaluation 2% Chlorhexidine Gluconate 2% CHG - Skin Coverage | Phase 2 | Completed | Medline Industries | 30 | 2016-11-16 | 2023-09-28 |
| Clinical Evaluation of Patient Preoperative Prep ZuraPrep, ChloraPrep, ZP Vehicle - Surgical Skin Preparation | Phase 3 | Completed | Zurex Pharma, Inc. | 640 | 2016-08-03 | 2021-07-16 |
| In-vivo Efficacy of Patient Preoperative Prep ZuraPrep, ChloraPrep, ZP Vehicle - Surgical Skin Preparation | Phase 3 | Completed | Zurex Pharma, Inc. | 440 | 2016-07-27 | 2023-02-08 |
| Pilot Clinical Evaluation to Characterize in Vivo Effects of Topically Applied ZuraPrep & ZuraPrep Vehicle ZuraPrep with 70% IPA, ZuraPrep without 70% IPA, ChloraPrep CHG/IPA Teal Tint - Surgical Site Infection | Phase 3 | Completed | Zurex Pharma, Inc. | 123 | 2015-10-01 | 2017-07-17 |
| Effectiveness of Preoperative Surgical Scrubbing Using Clorhexidine Digluconate and Parachlorometaxylenol (ECP) Preparatory handwash, Preoperative surgical scrubbing using 3% PCMX, Preoperative surgical scrubbing using 4% CHG - Skin Diseases, Surgical Site Infection | Not applicable | Completed | Ricardo Becerro de Bengoa Vallejo | 30 | 2015-06-01 | 2017-05-31 |
| Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055) ZuraPrep, ChloraPrep - Surgical Site Infection | Phase 2 | Completed | Zurex Pharma, Inc. | 36 | 2014-11-01 | 2016-07-14 |
| Preoperative CHG Cloth on Healthy Subjects Chlorhexidine Gluconate, Vehicle, DynaHex-2 - Surgery | Phase 3 | Completed | Medline Industries | 879 | 2014-10-01 | 2021-04-30 |
| Evaluation of Two Hand Hygiene Products in ICUs hand antiseptic with CHG and alcohol, Alcohol hand sanitizer foam - Hand Hygiene Effectiveness | Phase 4 | Completed | Solventum US LLC | 51 | 2014-10-01 | 2024-10-23 |
| Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ Chloraprep, ZuraPrep, ZuraPrep Vehicle - Surgical Site Infection | Phase 2 | Terminated | Zurex Pharma, Inc. | 64 | 2014-08-01 | 2016-07-18 |
| In Vivo Efficacy Study of Patient Preoperative Preps 3M CHG/IPA Prep C, 3M CHG/IPA Prep CH, ChloraPrep - Bacterial Reduction Post-product Application | Phase 3 | Completed | 3M | 738 | 2014-07-01 | 2020-11-23 |
| Checklist to Prevent MRSA Surgical Site Infections Mupirocin, Chlorhexidine gluconate, Cefazolin - Surgical Site Infection | Not applicable | Completed | VA Office of Research and Development | 23005 | 2014-04-01 | 2026-03-31 |
Showing 20 of 25. Sign in to see all of them.
Surgical Wound Infection (8) · Community-Acquired Infections (1) · Fractures, Open (1) · Kidney Failure, Chronic (1) · Personal Satisfaction (1) · Skin Diseases (1) · Staphylococcal Infections (1) · Staphylococcal Skin Infections (1) · Surgical Wound Dehiscence (1) · Urethral Stricture (1) · Urinary Tract Infections (1) · Wound Infection (1)
Zurex Pharma, Inc. (6) · Solventum US LLC (4) · Medline Industries (2) · 3M (1) · C. R. Bard (1) · Henry M. Jackson Foundation for the Advancement of Military Medicine (1) · Johns Hopkins University (1) · National Healthcare Group, Singapore (1) · National Taiwan University Hospital (1) · Ricardo Becerro de Bengoa Vallejo (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · The University of Texas Medical Branch, Galveston (1) · University of Maryland, Baltimore (1) · University of Missouri-Columbia (1) · VA Office of Research and Development (1)
United States (18) · Canada (1) · Romania (1) · Singapore (1) · Spain (1) · Taiwan (1) · Turkey (Türkiye) (1)
M. Hamid Bashir, MD (2) · Abhishek Deshpande, MD, PhD (1) · Allen Yan Lun Liu (1) · Antonio F. Saad, MD (1) · Ayfer Ozbas, Prof.Dr. (1) · C Beausoleil (1) · Chris Beausoleil (1) · Don Kim Moore, MD (1) · Eli N. Perencevich, MD MS BS (1) · Gerard Slobogean, MD (1) · Hamid Bashir (1) · Hong He (1) · Jamie Miller, ADN (1) · M H Bashir, MD (1) · M. Hamid Barshir, MD (1)
PMID 32131912, PMID 21028984, PMID 29382400, PMID 30334981, PMID 31737738, PMID 32259266, PMID 32787892, PMID 33264808, PMID 33618788, PMID 33648577, PMID 36244384, PMID 36925849, PMID 37471087
2019 (1)